Alerts

ctDNA Is Becoming the New Argument Over Chemotherapy
New GALAXY data suggest ctDNA status may identify which patients with colorectal liver metastases benefit from adjuvant chemotherapy after surgery. The promise is precision. The danger is moving faster than the evidence.

Bangladesh’s Dengue Alarm Is Already Ringing

Europe Opens Another Lung Cancer Door to China-Origin Immunotherapy

In Australia, Cancer Medicine Delays Cost More Than Time

Wellness Powder Sent 32 People to Hospital

Fungal Disease Was Left Out of the AMR Fight

BRCA Care Cannot Start at Diagnosis

Duchenne’s Accelerated Approval Faces Its Test

The Screwworm Border Did Not Hold. Now Mexico and the U.S. Are Betting on Flies.

Europe Opens Another Lung Cancer Door to China-Origin Immunotherapy
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
